Serum uric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients

Nutrition

Volumn 31, Issue 1, 2015, Pages 138-147

  Beberashvili, Ilia ^a   Sinuani, Inna ^a   Azar, Ada ^a   Shapiro, Gregory ^a   Feldman, Leonid ^a   Stav, Kobi ^a   Sandbank, Judith ^a   Averbukh, Zhan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Handgrip strength; Hemodialysis; Malnutrition inflammation score; Quality of life; Survival; Uric acid

Indexed keywords

ALBUMIN; CREATININE; INTERLEUKIN 6; URIC ACID; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ADVERSE OUTCOME; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GERIATRIC ASSESSMENT; GERIATRIC NUTRITIONAL RISK INDEX; GRIP STRENGTH; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION INFLAMMATION SCORE; MORTALITY; MUSCLE FUNCTION; NUTRITIONAL ASSESSMENT; NUTRITIONAL DISORDER; OBSERVATIONAL STUDY; OUTPATIENT; PHYSICAL PERFORMANCE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RISK ASSESSMENT; SCORING SYSTEM; SHORT FORM 36; SURVIVAL RATE; TREATMENT DURATION; URIC ACID BLOOD LEVEL; BLOOD; BODY MASS; CALORIC INTAKE; HAND STRENGTH; METABOLISM; MIDDLE AGED; NUTRITIONAL STATUS; RENAL REPLACEMENT THERAPY; RISK FACTOR; SKINFOLD THICKNESS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; BODY COMPOSITION; BODY MASS INDEX; CREATININE; ENERGY INTAKE; FEMALE; HAND STRENGTH; HOSPITALIZATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; SKINFOLD THICKNESS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; URIC ACID;

EID: 84922220391     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.06.012     Document Type: Article

References (59)

1. Carrero J.J., Chmielewski M., Axelsson J., Snaedal S., Heimbüger O., Bárány P., et al. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr 2008, 27:557-564.
2. de Mutsert R., Grootendorst D.C., Axelsson J., Boeschoten E.W., Krediet R.T., Dekker F.W. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 2008, 23:2957-2964. NECOSAD Study Group.
3. Fouque D., Kalantar-Zadeh K., Kopple J., Cano N., Chauveau P., Cuppari L., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008, 73:391-398.
4. Locatelli F., Fouque D., Heimburger O., Drüeke T.B., Cannata-Andia J.B., Hörl W.H., et al. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant 2002, 17:563-572.
5. Choi H.K., Mount D.B., Reginato A.M. Pathogenesis of gout. Ann Intern Med 2005, 143:499-516.
6. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
7. Alper A.B., Chen W., Yau L., Srinivasan S., Hamm L.L., Berenson G. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 2005, 45:34-38.
8. Syamala S., Li J., Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007, 25:1583-1589.
9. Shankar A., Klein B.E., Nieto F.J., Klein R. Association between serum uric acid level and peripheral arterial disease. Atherosclerosis 2008, 196:749-755.
10. Bandaru P., Shankar A. Association between serum uric acid levels and diabetes mellitus. Int J Endocrinol 2011, 2011:604715.
11. Feig D.I. Uric acid: a novel mediator and marker of risk in chronic kidney disease?. Curr Opin Nephrol Hypertens 2009, 18:526-530.
12. Verdecchia P., Schillaci G., Reboldi G., Santeusanio F., Porcellati C., Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000, 36:1072-1078.
13. Gagliardi A.C., Miname M.H., Santos R.D. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009, 202:11-17.
14. Hsu S.P., Pai M.F., Peng Y.S., Chiang C.K., Ho T.I., Hung K.Y. Serum uric acid levels show a "J-shaped" association with all-cause mortality in haemodialysis. Nephrol Dial Transplant 2004, 19:457-462.
15. Suliman M.E., Johnson R.J., García-López E., Qureshi A.R., Molinaei H., Carrero J.J., et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 2006, 48:761-771.
16. Feng S., Jiang L., Shi Y., Shen H., Shi X., Jin D., et al. Uric acid levels and all-cause mortality in peritoneal dialysis patients. Kidney Blood Press Res 2013, 37:181-189.
17. Latif W., Karaboyas A., Tong L., Wincgester J.F., Arrington C.J., Pisoni R.L., et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol 2011, 6:2470-2477.
18. Lee S.M., Lee A.L., Winters T.J., Tam E., Jaleel M., Stenvinkel P., et al. Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol 2009, 29:79-85.
19. Kalantar-Zadeh K., Block G., Humphreys M.H., Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003, 63:793-808.
20. Chen Y., Ding X., Teng J., Zou J., Zhong Y., Fang Y., et al. Serum uric acid is inversely related to acute ischemic stroke morbidity in hemodialysis patients. Am J Nephrol 2011, 33:97-104.
21. Choi H.K., Liu S., Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005, 52:283-289.
22. de Oliveira E.P., Moreto F., Silveira L.V., Burini R.C. Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults. Nutr J 2013, 12:11.
23. Bross R., Noori N., Kovesdy C.P., Murali S.B., Benner D., Block G., et al. Dietary assessment of individuals with chronic kidney disease. Semin Dial 2010, 23:359-364.
24. Fouque D., Vennegoor M., ter Wee P., Wanner C., Basci A., Canaud B., et al. EBPG guideline on nutrition. Nephrol Dial Transplant 2007, 22(Suppl 2):ii45-ii87.
25. Human Nutrition Center, University of Texas-Houston, School of Public Health, Human Nutrition Center. Available at:. Accessed June 9, 2014. http://www.sph.uth.edu.tmc:8052/hnc/software/soft.html.
26. Depner T.A., Daugirdas J.T. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 1996, 7:780-785.
27. Kalantar-Zadeh K., Kopple J.D., Block G., Humphreys M.H. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001, 38:1251-1263.
28. Kalantar-Zadeh K., Kopple J.D., Humphreys M.H., Block G. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004, 19:1507-1519.
29. Bouillanne O., Morineau G., Dupont C., Coulombel I., Vincent J.P., Nicolis I., et al. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 2005, 82:777-783.
30. Kalantar-Zadeh K., Kopple J.D., Block G., Humphreys M.H. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 2001, 12:2797-2806.
31. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Manuel Gómez J., et al. Bioelectrical impedance analysis- part II: utilization in clinical practice. Clin Nutr 2004, 23:1430-1453.
32. Liu J., Huang Z., Gilbertson D.T., Foley R.N., Collins A.J. An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int 2010, 77:141-151.
33. Harrell F.E. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis 2001, Springer, New York.
34. Kalantar-Zadeh K., Kilpatrick R.D., Kuwae N., McAllister C.J., Alcorn H., Koople J.D., et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005, 20:1880-1888.
35. Pifer T.B., McCullough K.P., Port F.K., Goodkin D.A., Maroni B.J., Held P.J., et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002, 62:2238-2245.
36. Jialin W., Yi Z., Weijie Y. Relationship between body mass index and mortality in hemodialysis patients: a meta-analysis. Nephron Clin Pract 2012, 121:c102-c111.
37. Noori N., Kopple J.D., Kovesdy C.P., Feroze U., Sim J.J., Murali S.B., et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2010, 5:2258-2268.
38. Noori N., Kovesdy C.P., Dukkipati R., Kim Y., Duong U., Bross R., et al. Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis. Am J Clin Nutr 2010, 92:1060-1070.
39. Shinaberger C.S., Kilpatrick R.D., Regidor D.L., McAllister C.J., Greenland S., Kopple J.D., et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 2006, 48:37-49.
40. Heimbürger O., Qureshi A.R., Blaner W.S., Berglund L., Stenvinkel P. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000, 36:1213-1225.
41. Stenvinkel P., Barany P., Chung S.H., Lindholm B., Heimbürger O. A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 2002, 17:1266-1274.
42. Wang A.Y., Sea M.M., Ho Z.S., Lui S.F., Li P.K., Woo J. Evaluation of handgrip strength as a nutritional marker and prognostic indicator in peritoneal dialysis patients. Am J Clin Nutr 2005, 81:79-86.
43. Feroze U., Noori N., Kovesdy C.P., Molnar M.Z., Martin D.J., Reina-Patton A., et al. Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc Nephrol 2011, 6:1100-1111.
44. Spiegel B.M., Melmed G., Robbins S., Esrailian E. Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol 2008, 3:1759-1768.
45. Beberashvili I., Azar A., Sinuani I., Kadoshi H., Shapiro G., Feldman L., et al. Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemodialysis patients. Clin J Am Soc Nephrol 2013, 8:443-451.
46. Matsuura F., Yamashita S., Nakamura T., Nishida M., Nozaki S., Funahashi T., et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 1998, 47:929-933.
47. Young D.O., Lund R.J., Haynatzki G., Dunlay R.W. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial Int 2007, 11:86-95.
48. Xie Q., Zhang A.H., Chen S.Y., Lai X., Zhang F., He L., et al. Metabolic syndrome is associated with better nutritional status, but not with cardiovascular disease or all-cause mortality in patients on haemodialysis. Arch Cardiovasc Dis 2012, 105:211-217.
49. Panichi V., Maggiore U., Taccola D., Migliori M., Rizza G.M., Consani C., et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in dialytic patients. Nephrol Dial Transplant 2004, 19:1154-1160.
50. Khosla U.M., Zharikov S., Finch J.L., Nakagawa T., Roncal C., Mu W., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742.
51. Kang D.H., Park S.K., Lee I.K., Johnson R.J. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005, 16:3553-3562.
52. Schreiner O., Wandel E., Himmelsbach F., Galle P.R., Märker-Hermann E. Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?. Nephrol Dial Transplant 2000, 15:644-649.
53. Beberashvili I., Azar A., Sinuani I., Kadoshi H., Shapiro G., Feldman L., et al. Longitudinal changes in bioimpedance phase angle reflect inverse changes in serum IL-6 levels in maintenance hemodialysis patients. Nutrition 2014, 30:297-304.
54. Simie M.G., Jovanovic S.V. Antioxidation mechanisms of uric acid. J Am Chem Soc 1989, 111:5778-5782.
55. Mezzano D., Pais E.O., Aranda E., Panes O., Downey P., Ortiz M., et al. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 2001, 60:1844-1850.
56. Dong J., Han Q.F., Zhu T.Y., Ren Y.P., Chen J.H., Zhao H.P., et al. The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients. PLoS One 2014, 9:e82342.
57. Xia X., He F., Wu X., Peng F., Huang F., Yu X. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis. Am J Kidney Dis 2014, 64:257-264.
58. Qureshi A.R., Alvestrand A., Divino-Filho J.C., Gutierrez A., Heimbürger O., Lindholm B., et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002, 13(Suppl 1):S28-S36.
59. Yeun J.Y., Levine R.A., Mantadilok V., Kaysen G.A. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000, 35:469-476.